Gland Pharma Vice President Ankit Gupta Resigns to Pursue New Opportunities
Team Finance Saathi
03/Dec/2024

What's covered under the Article:
- Ankit Gupta resigns as Vice President (Strategy, Investments & Investor Relations) of Gland Pharma.
- The resignation was accepted by the Nomination and Remuneration Committee on December 3, 2024.
- His official duties will end on December 31, 2024, and he will cease to be part of the senior management starting January 1, 2025.
Gland Pharma Limited has announced that Ankit Gupta, the Vice President overseeing Strategy, Investments, and Investor Relations, has tendered his resignation to pursue other professional opportunities. His resignation was formally accepted and approved by the Nomination and Remuneration Committee of the Board of Directors on December 3, 2024. As per the company’s disclosure, Ankit Gupta will be relieved from his duties at the close of business hours on December 31, 2024, and he will cease to be a Senior Management Personnel (SMP) starting January 1, 2025.
This move follows the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates timely disclosure of such events. The company has filed the necessary disclosures with the BSE and NSE. Gupta’s resignation has been documented in the official letters, with the relevant details outlined in Annexure A and Annexure B of the filing.
Gupta’s departure marks a significant change in Gland Pharma’s senior management team. In his resignation letter, Ankit Gupta expressed gratitude for his tenure at Gland Pharma, acknowledging the opportunities he was afforded both in India and at Cenexi. He mentioned that the decision was not an easy one, as he has enjoyed his time with the company. However, he is looking forward to pursuing a new opportunity that aligns with his long-term professional goals. He has committed to ensuring a smooth transition and assisting in handing over his responsibilities.
For further updates on leadership changes and corporate disclosures, investors and stakeholders are advised to follow the BSE and NSE announcements. Gland Pharma continues to move forward with its strategic initiatives and remains a significant player in the pharmaceutical industry.
The Upcoming IPOs in this week and coming weeks are Nisus Finance, Emerald Tyre Manufacturers, Jungle Camps, Purple United, Rosmerta Digital and Avanse Financial.The Current active IPO is Ganesh Infraworld and Suraksha Diagnostic.For more details on upcoming IPOs, you can visit our page at Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated with the latest news on IPO updates on Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi.Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in Choice Broking FinX.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.